Hikal resumes production at Taloja site

29 Oct 2019 Evaluate

Hikal has resumed normal production at Taloja site post the 100% restoration of water by MIDC. Pursuant to the Supreme Court order, MIDC has restored 100% supply of water to the Taloja MIDC zone on October 25, 2019. MIDC had cut 50% of the water supply last quarter which severely affected the operations in Q2 of FY20 resulting in lower production and sales.

Further, the Mahad site which was affected by heavy flooding in Q2FY20 resulting in a loss of production has also resumed normal production.

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries.

Hikal Share Price

242.40 -10.55 (-4.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×